
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, et al.
Nature (2023) Vol. 617, Iss. 7961, pp. 592-598
Open Access | Times Cited: 109
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, et al.
Nature (2023) Vol. 617, Iss. 7961, pp. 592-598
Open Access | Times Cited: 109
Showing 1-25 of 109 citing articles:
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 550
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 550
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 148-156
Open Access | Times Cited: 144
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 148-156
Open Access | Times Cited: 144
Molecular fate-mapping of serum antibody responses to repeat immunization
Ariën Schiepers, Marije F. L. van ’t Wout, Allison J. Greaney, et al.
Nature (2023) Vol. 615, Iss. 7952, pp. 482-489
Open Access | Times Cited: 112
Ariën Schiepers, Marije F. L. van ’t Wout, Allison J. Greaney, et al.
Nature (2023) Vol. 615, Iss. 7952, pp. 482-489
Open Access | Times Cited: 112
Immunological imprinting: Understanding COVID-19
Marios Koutsakos, Ali H. Ellebedy
Immunity (2023) Vol. 56, Iss. 5, pp. 909-913
Open Access | Times Cited: 59
Marios Koutsakos, Ali H. Ellebedy
Immunity (2023) Vol. 56, Iss. 5, pp. 909-913
Open Access | Times Cited: 59
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
M. Alejandra Tortorici, Amin Addetia, Albert J. Seo, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 904-911.e4
Open Access | Times Cited: 54
M. Alejandra Tortorici, Amin Addetia, Albert J. Seo, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 904-911.e4
Open Access | Times Cited: 54
Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine
Qian Wang, Yicheng Guo, Anthony Raymond Tam, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101258-101258
Open Access | Times Cited: 50
Qian Wang, Yicheng Guo, Anthony Raymond Tam, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101258-101258
Open Access | Times Cited: 50
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines
Spyros Chalkias, Nichole McGhee, Jordan L. Whatley, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. e279-e286
Open Access | Times Cited: 47
Spyros Chalkias, Nichole McGhee, Jordan L. Whatley, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. e279-e286
Open Access | Times Cited: 47
Evolution of antibody immunity following Omicron BA.1 breakthrough infection
Chengzi I. Kaku, Tyler N. Starr, Pan-Pan Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Chengzi I. Kaku, Tyler N. Starr, Pan-Pan Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
Spyros Chalkias, Jordan L. Whatley, Frank Eder, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2325-2333
Open Access | Times Cited: 44
Spyros Chalkias, Jordan L. Whatley, Frank Eder, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2325-2333
Open Access | Times Cited: 44
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
Juan Manuel Carreño, Gagandeep Singh, Viviana Simon, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 8, pp. e569-e569
Open Access | Times Cited: 40
Juan Manuel Carreño, Gagandeep Singh, Viviana Simon, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 8, pp. e569-e569
Open Access | Times Cited: 40
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
Komal Srivastava, Juan Manuel Carreño, Charles Gleason, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 587-599.e4
Open Access | Times Cited: 34
Komal Srivastava, Juan Manuel Carreño, Charles Gleason, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 587-599.e4
Open Access | Times Cited: 34
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
Timothy S. Johnston, Shuk Hang Li, Mark M. Painter, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 912-925.e4
Open Access | Times Cited: 31
Timothy S. Johnston, Shuk Hang Li, Mark M. Painter, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 912-925.e4
Open Access | Times Cited: 31
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 950-960
Closed Access | Times Cited: 29
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 950-960
Closed Access | Times Cited: 29
Immunological memory diversity in the human upper airway
Sydney I. Ramirez, Farhoud Faraji, L. Benjamin Hills, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 630-636
Closed Access | Times Cited: 21
Sydney I. Ramirez, Farhoud Faraji, L. Benjamin Hills, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 630-636
Closed Access | Times Cited: 21
Immune imprinting and next-generation coronavirus vaccines
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1971-1985
Closed Access | Times Cited: 38
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1971-1985
Closed Access | Times Cited: 38
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Variant-adapted COVID-19 booster vaccines
Florian Krammer, Ali H. Ellebedy
Science (2023) Vol. 382, Iss. 6667, pp. 157-159
Open Access | Times Cited: 34
Florian Krammer, Ali H. Ellebedy
Science (2023) Vol. 382, Iss. 6667, pp. 157-159
Open Access | Times Cited: 34
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses
Kristen W. Cohen, Stephen C. De Rosa, William J. Fulp, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 697
Closed Access | Times Cited: 27
Kristen W. Cohen, Stephen C. De Rosa, William J. Fulp, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 697
Closed Access | Times Cited: 27
Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases
Michelle W. Cheung, Roya M. Dayam, Janna R. Shapiro, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 3, pp. 351-364
Open Access | Times Cited: 23
Michelle W. Cheung, Roya M. Dayam, Janna R. Shapiro, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 3, pp. 351-364
Open Access | Times Cited: 23
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 10
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 10
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants
Shilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Shilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans
Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Open Access | Times Cited: 8
Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Open Access | Times Cited: 8
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
Wen Shi Lee, Hyon‐Xhi Tan, Arnold Reynaldi, et al.
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 20
Wen Shi Lee, Hyon‐Xhi Tan, Arnold Reynaldi, et al.
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 20